Isabel Püntmann

426 total citations
4 papers, 98 citations indexed

About

Isabel Püntmann is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, Isabel Püntmann has authored 4 papers receiving a total of 98 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Endocrinology, Diabetes and Metabolism, 1 paper in Molecular Biology and 1 paper in Pharmacology. Recurrent topics in Isabel Püntmann's work include Diabetes Management and Research (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper) and Medication Adherence and Compliance (1 paper). Isabel Püntmann is often cited by papers focused on Diabetes Management and Research (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper) and Medication Adherence and Compliance (1 paper). Isabel Püntmann collaborates with scholars based in Germany and Sweden. Isabel Püntmann's co-authors include Rainer Haeckel, Werner Wosniok, Jörg Schneider, Bernd Mühlbauer, Gunnar Lindberg, Iris Pigeot, Wolfgang Ahrens, Jürgen Timm, Arne Melander and Norbert Schmacke and has published in prestigious journals such as Clinical Chemistry, Clinical Chemistry and Laboratory Medicine (CCLM) and Pharmacoepidemiology and Drug Safety.

In The Last Decade

Isabel Püntmann

4 papers receiving 92 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Püntmann Germany 4 49 20 17 14 14 4 98
M. K. Sullivan United States 4 11 0.2× 5 0.3× 5 0.3× 31 2.2× 10 0.7× 9 66
Jeannette Majert United Kingdom 3 32 0.7× 8 0.4× 7 0.4× 11 0.8× 6 0.4× 4 88
A. López-Alba France 2 60 1.2× 7 0.3× 8 0.5× 3 0.2× 10 0.7× 3 75
Elizabeth da Rosa Duarte Brazil 3 86 1.8× 4 0.2× 9 0.5× 7 0.5× 10 0.7× 5 109
Yong Du China 4 53 1.1× 5 0.3× 9 0.5× 9 0.6× 7 0.5× 5 92
Zili Yang China 3 34 0.7× 5 0.3× 10 0.6× 8 0.6× 3 0.2× 4 77
Kwame Osei United States 4 32 0.7× 3 0.1× 7 0.4× 14 1.0× 7 0.5× 4 86
Amer Rassam United States 4 81 1.7× 3 0.1× 19 1.1× 8 0.6× 23 1.6× 6 112
J Connell United Kingdom 3 37 0.8× 2 0.1× 10 0.6× 8 0.6× 4 0.3× 6 72
P Pata Italy 2 41 0.8× 4 0.2× 8 0.5× 4 0.3× 3 0.2× 2 49

Countries citing papers authored by Isabel Püntmann

Since Specialization
Citations

This map shows the geographic impact of Isabel Püntmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Püntmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Püntmann more than expected).

Fields of papers citing papers by Isabel Püntmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Püntmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Püntmann. The network helps show where Isabel Püntmann may publish in the future.

Co-authorship network of co-authors of Isabel Püntmann

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Püntmann. A scholar is included among the top collaborators of Isabel Püntmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Püntmann. Isabel Püntmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Püntmann, Isabel, Norbert Schmacke, Arne Melander, Gunnar Lindberg, & Bernd Mühlbauer. (2010). EVITA: a tool for the early EValuation of pharmaceutical Innovations with regard to Therapeutic Advantage. PubMed. 10(1). 5–5. 11 indexed citations
2.
Ahrens, Wolfgang, et al.. (2007). Hospitalization rates of generic metoprolol compared with the original beta‐blocker in an epidemiological database study. Pharmacoepidemiology and Drug Safety. 16(12). 1298–1307. 17 indexed citations
3.
Püntmann, Isabel, Werner Wosniok, & Rainer Haeckel. (2003). Comparison of Several Point-of-Care Testing (POCT) Glucometers with an Established Laboratory Procedure for the Diagnosis of Type 2 Diabetes Using the Discordance Rate. A New Statistical Approach. Clinical Chemistry and Laboratory Medicine (CCLM). 41(6). 809–20. 33 indexed citations
4.
Haeckel, Rainer, et al.. (2002). Comparability of Blood Glucose Concentrations Measured in Different Sample Systems for Detecting Glucose Intolerance. Clinical Chemistry. 48(6). 936–939. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026